Home/Evommune/Daniel J. Burge, M.D.
DJ

Daniel J. Burge, M.D.

Senior Vice President, Clinical Development

Evommune

Evommune Pipeline

DrugIndicationPhase
EVO756Chronic Spontaneous UrticariaPhase 2b
EVO301Atopic DermatitisPhase 2